Stocks to Watch, Jan 9, 2025: TCS, TaMo, M&M, Manappuram Finance, LIC, MOIL

Q: How long will it take to read this news story?

The story "Stocks to Watch, Jan 9, 2025: TCS, TaMo, M&amp;M, Manappuram Finance, LIC, MOIL" has 695 words across 27 sentences, which will take approximately 3 - 6 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Stocks to Watch, Jan 9, 2025: TCS, TaMo, M&amp;M, Manappuram Finance, LIC, MOIL" was covered 15 hours ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of 328 news stories per day. It's most recent story was published 2 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #24988493</li><li>URL: https://beamstart.com/news/stocks-to-watch-jan-9-17363898749744</li></ul>

Business Standard Logo Business Standard 15h ago

Stocks to Watch, Jan 9, 2025: TCS, TaMo, M&M, Manappuram Finance, LIC, MOIL - Business Standard

Quick Summary:

Mahindra & Mahindra (M&M): M&M has de-risked its semiconductor supply chain for its new electric vehicles (EVs) BE 6 and XEV 9e, which were unveiled in November last year and deliveries expected to commence in March, as per reports.

Adani Ports: The company entered the global top 10 list of transportation and transportation infrastructure companies in the S&P Global Corporate Sustainability Assessment (CSA) rankings for 2024.

Lupin: The company received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA) for its Pithampur Unit-1 manufacturing facility that manufactures both APIs and finished products.